Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidepressant |
| gptkbp:activeIngredient |
mianserin
|
| gptkbp:affiliatedWith |
antidepressant
|
| gptkbp:approvedBy |
1970s
|
| gptkbp:ATCCode |
N06AX03
|
| gptkbp:availableOn |
gptkb:Australia
gptkb:United_Kingdom |
| gptkbp:chemicalFormula |
C18H20N2
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:eliminationHalfLife |
21-61 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tolvon
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Organon
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
dizziness weight gain drowsiness dry mouth |
| gptkbp:synonym |
mianserin hydrochloride
|
| gptkbp:usedFor |
treatment of depression
|
| gptkbp:bfsParent |
gptkb:Mianserin
|
| gptkbp:bfsLayer |
7
|